Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease. Issue 5 (4th May 2015)

• Record Type: Journal Article
• Authors: Danelich, Ilya M.; Wright, Sampaguita S.; Lose, Jennifer M.; Tefft, Brittany J.; Cicci, Jonathan D.; Reed, Brent N.
• Is Part Of: Pharmacotherapy. Volume 35:Issue 5(2015)
• Page Start: 520
• Page End: 535
• Publication Date: 2015-05-04
• Subjects: Chemotherapy -- Periodicals; Pharmacology -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1002/phar.1584
• Languages: English
• ISSNs: 0277-0008

Abstract

<abstract abstract-type="main" id="phar1584-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Nonsteroidal antiinflammatory drugs (NSAIDs) are used in the management of a variety of conditions, but their prevalence is likely underreported as a result of widespread availability and the perception that nonprescription therapies are unnecessary to report during medication history taking. However, NSAIDs are associated with a number of adverse effects, especially in patients with cardiovascular disease (CVD). Patients with CVD and comorbidities for which NSAIDs may provide symptomatic relief (e.g., osteoarthritis, rheumatoid arthritis) tend to be older, which places them at greater risk of harm. For these reasons, the use of NSAIDs in patients with CVD is a significant public health concern. An understanding of the risks associated with NSAIDs is critical for clinicians across practice settings. In this review, we detail the safety of NSAIDs in patients with CVD, provide recommendations on their use in specific disease states, and discuss therapeutic alternatives.</p> </abstract>